How a torrent of COVID science changed research publishing - in seven charts.

@article{Else2020HowAT,
  title={How a torrent of COVID science changed research publishing - in seven charts.},
  author={Holly Else},
  journal={Nature},
  year={2020},
  volume={588 7839},
  pages={
          553
        }
}

Strengths and Weaknesses of the Research Enterprise During the Pandemic

  • A. Lewis
  • Medicine
    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
  • 2022
TLDR
The strengths and weaknesses of the research enterprise’s response to questions about the transmission, morbidity and mortality and treatment of COVID-19 are reflected based on a review of publication volume, authorship and collaboration, the peer review process, and the accessibility, impact and quality of papers written about CO VID-19.

Reproducibility of COVID-19 pre-prints

To examine the reproducibility of COVID-19 research, we create a dataset of pre-prints posted to arXiv, bioRxiv, and medRxiv between 28 January 2020 and 30 June 2021 that are related to COVID-19. We

“The personal is political”: Practising reflexivity during the pandemic

Gordon, Sarah Frances “The personal is political”: Practising reflexivity during the pandemic Psicología Iberoamericana, vol. 29, núm. 2, e292418, 2022 Universidad Iberoamericana, Ciudad de México,

The Year 2020 in Review: Coronavirus Disease 2019 Cloud and Its Impact Excelling the Clinical Practice

TLDR
This current issue is to summarize all the salient publications that happened in the year 2020 broadly into 6 categories pertinent to the readership, namely, cardiothoracic anesthesiology, anesthesia for congenital heart disease (CHD), thoracic transplant anesthesiological, cardo-critical care, abdominal organ transplantation, and cardiotheracic surgery.

Requiem for impact factors and high publication charges

TLDR
It is argued that new approaches to assessment are required to provide a realistic and comprehensive measure of the value of research and journals and open access publishing at a modest, affordable price to benefit research producers and consumers.

Invited Commentary: Toward a Better Understanding of Disparities in Overdose Mortality

TLDR
The authors found that combinations of opioid/stimulant drug overdose deaths saw a steep increase among racial and ethnic minorities, particularly Black Americans, between 2007 and 2019, highlighting the need to change the narrative around opioid deaths.

Artigos Retratados Sobre COVID-19: Uma Análise Sobre Sua Rede de Citações

Para auxiliar no enfrentamento à pandemia da COVID-19, pesquisas foram aceleradas, acarretando em muitos artigos sendo publicados apressadamente, alguns destes sofrendo retratações. Neste trabalho

How emotions from content social relevance mediate social media engagement: evidence from European supermarkets during the COVID-19 pandemic

PurposeThe purpose of this study is to examine the antecedents of consumer engagement with supermarkets' social media accounts. Drawing on regulatory fit theory and social sharing of emotions theory,

Citation premium: a much higher proportion of COVID-19 related publications become highly cited papers

: With the global spread of the COVID-19 pandemic, scientists from various disciplines responded quickly to this historical public health emergency. The sudden boom of COVID-19 related papers in a
...

References

SHOWING 1-5 OF 5 REFERENCES

International collaboration during the COVID-19 crisis: autumn 2020 developments

TLDR
COVID-19 research has fewer nations and smaller teams than pre-COVID research, a trend which intensifies throughout the pandemic, but the United States remains the single largest contributor to the global publication output.

Only Second-Class Tickets for Women in the COVID-19 Race. A Study on Manuscript Submissions and Reviews in 2329 Elsevier Journals

During the early months of the COVID-19 pandemic, the submission rate to scholarly journals increased abnormally (e.g., more than 90% in health & medicine Elsevier journals). Given that most

The proximal origin of SARS-CoV-2

TLDR
It is shown that SARS-CoV-2 is not a laboratory construct or a purposefully manipulated virus, and scenarios by which they could have arisen are discussed.

Chloroquine is a potent inhibitor of SARS coronavirus infection and spread

TLDR
Chloroquine is effective in preventing the spread of SARS CoV in cell culture and the indirect immunofluorescence assay described herein represents a simple and rapid method for screening SARS-CoV antiviral compounds.